3 ms·

The EU lacks the power to do that kind of enforcement. It surprisingly quickly turns into a military and hard power question, which the EU lacks considering it’

• jdiez17 3y ago
  How quickly, exactly? Do you think the US military would step in to resolve a dispute regarding a consumer electronics company? > considering it’s the GDP of all these evil tech companies that’s paying for their national security and health care I find the logic of the article you linked highly questionable. > Certainly it is more difficult than what drug companies do now, which is to set a high U.S. price, assuring profitability, no matter how thin the profit margin on European sales. So there is a profit margin, right? Otherwise drug companies wouldn't sell their products in Europe. It seems that this article and the MFN legislation is worried about the high drug prices in the US. Fair enough, I suppose, but how exactly is that "subsidizing the European health system"? > The goal of the MFN concept is to deliver fair prices to Americans without diminishing drug company profits. So you are specifically protecting the drug companies' massive *profits*. Not research or production costs, profits. > Since the introduction of the Medicare Part D prescription drug benefit, Medicare has been prohibited by law from using its volume-purchasing power to negotiate prices for the drugs it covers, while government-run European health authorities have used such volume-purchasing power to obtain drastically low prices. That seems very dumb.